Clinical ResearchMediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Supported by Janssen Research & Development. Drs. Li and Woodward are employees of the George Institute. Dr. Perkovic has received research support from the Australian National Health and Medical Research Council (Senior Research Fellowship and Program Grant); and has been a member of the steering committees for AbbVie, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Novartis, and Pfizer; and has served on advisory boards and/or as a speaker at scientific meetings for AbbVie, Astellas, AstraZeneca, Bayer, Baxter, Bristol-Myers Squibb, Boehringer Ingelheim, Durect, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Merck, Novartis, Novo Nordisk, Pfizer, Pharmalink, Relypsa, Retrophin, Roche, Sanofi, Servier, and Vitae. Dr. Figtree has received research support from the cofunded Australian National Health and Medical Research Council and Heart Foundation fellowship and Heart Research Australia; and has received compensation from Janssen for serving on the adjudication panel of the CANVAS Program. Dr. Heerspink has served as a consultant for AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Fresenius, Gilead, Janssen, Merck, and Mitsubishi Tanabe; and has received research support from AbbVie, AstraZeneca, Boehringer Ingelheim, and Janssen. Dr. Mahaffey has received research grants/contracts from Afferent, Amgen, Apple, Inc., AstraZeneca, Cardiva Medical, Inc., Daiichi, Ferring, Google (Verily), Johnson & Johnson, Luitpold, Medtronic, Merck, National Institutes of Health (NIH), Novartis, Sanofi, St. Jude, and Tenax; and has served as a consultant for Abbott, Ablynx, AstraZeneca, Baim Institute, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Medscape, Mitsubishi, Myokardia, NIH, Novartis, Novo Nordisk, Portola, Radiometer, Regeneron, SmartMedics, Springer Publishing, and University of California, San Francisco (UCSF). Dr. de Zeeuw has served on advisory boards and/or as a speaker for Bayer, Boehringer Ingelheim, Fresenius, Mundipharma, and Mitsubishi Tanabe; and has served on steering committees for AbbVie and Janssen; and has served on data safety and monitoring committees for Bayer. Drs. Vercruysse and Shaw are employees of Janssen Research & Development. Dr. Matthews has received research support from Janssen; and has served on advisory boards and as a consultant for Novo Nordisk, Novartis, Eli Lilly, Sanofi, Janssen, and Servier; and has given lectures for Novo Nordisk, Servier, Sanofi, Eli Lilly, Novartis, Janssen, Mitsubishi Tanabe, and Aché Laboratories; and currently serves as president of the European Association for the Study of Diabetes (EASD). Dr. Neal has received research support from the Australian National Health and Medical Research Council principal research fellowship; and has served on advisory boards and/or as a consultant for Janssen and Merck Sharpe & Dohme, with any consultancy, honoraria, or travel support paid to his institution. The George Institute for Global Health holds multiple additional commercial contracts with a diverse range of entities.